Clinical Trials Logo

Clinical Trial Summary

This study aims to conduct a detailed analysis of the immunological response profiles that emerge at different clinical stages of medication-related osteonecrosis of the jaw (MRONJ). The research seeks to understand how these responses influence the pathogenesis, staging, and treatment of MRONJ. Throughout the study, cytokine levels, inflammation markers, and other immunological parameters observed at various stages will be comprehensively assessed. The results of these analyses are expected to provide insights into how stage-specific immunological variables could play a role in the diagnosis and treatment of MRONJ.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06420284
Study type Observational
Source Marmara University
Contact Ferit Bayram, PhD
Phone 00902167775000
Email ferit.bayram@marmara.edu.tr
Status Recruiting
Phase
Start date May 1, 2024
Completion date May 1, 2025